NCT03958253

Brief Summary

The successful implementation of lung cancer screening across diverse setting requires working with the community and primary care practices. Collaborating across diverse community-based sites will employ local knowledge and culture in the understanding of the health problem and identifying and implementing solutions that are appropriate for all partners (patients, primary care, referral centers). Enhanced, culturally-competent communication with patients at high risk for lung cancer can narrow inequities in screening awareness, referral, and utilization, as well as improve lung cancer outcomes across diverse patients and communities. Promoting partnerships among physicians, staff, and patients; creating routines; and tailoring materials to each clinician's situation have been show to increase the proportion of patients receiving screening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
193

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2019

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 21, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

1.9 years

First QC Date

May 17, 2019

Last Update Submit

April 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of initial low-dose CT (LDCT) scan screenings per month per screening center

    -Screening will be defined as completed initial screen for lung cancer

    Completion of study (estimated to be 21 months)

Secondary Outcomes (3)

  • Number of primary care providers who refer at least two patients per month for LDCT

    Completion of study (estimated to be 21 months)

  • Percent of patients referred who are screen-eligible

    Completion of study (estimated to be 21 months)

  • Percent of patients referred who complete screening

    Completion of study (estimated to be 21 months)

Study Arms (1)

Lung Cancer Screening Toolbox

EXPERIMENTAL

* WU Staff will train local screening staff using a train-the-trainer model three months prior to the intervention and will provide technical assistance on an ongoing basis. * During the 3 hour train-the-trainer session, the selected staff from the referral sites will learn about the program, receive an orientation to the toolbox elements, and discuss how to adapt the elements of the toolbox to their referral sites.

Other: Toolbox for Lung Cancer Screening

Interventions

-Toolbox of evidence-based elements that a primary care or referral site could implement to address known barriers to screening and referral, as well as required elements for screening. These elements will be designed to be adaptable to the unique needs and screening processes of the participating practices. * Patient education materials * Primary care practice educational materials * Pack-years/eligibility calculator * Local referral process guide * Smoking cessation materials and support * Shared decision-making guide * LDCT best practice guidelines

Lung Cancer Screening Toolbox

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To be eligible to participate in the trial, screening centers have to be existing members of the BJC Collaborative.
  • Primary Care Providers have to have a referral relationship with the screening center; serve adult patients who may be screening-eligible, and are willing to interact with the referral site to implement referral for LDCT.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Southern Illinois Healthcare

Carbondale, Illinois, 62901, United States

Location

Decatur Memorial Hospital

Decatur, Illinois, 62526, United States

Location

Sarah Bush Lincoln Health System

Mattoon, Illinois, 61938, United States

Location

Memorial Health System

Springfield, Illinois, 62702, United States

Location

BJC HealthCare, Barnes-Jewish St. Peters Hospital

City of Saint Peters, Missouri, 63376, United States

Location

CoxHealth

Springfield, Missouri, 65802, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Publications (1)

  • Salazar AS, Sekhon S, Rohatgi KW, Nuako A, Liu J, Harriss C, Brennan E, LaBeau D, Abdalla I, Schulze C, Muenks J, Overlot D, Higgins JA, Jones LS, Swick C, Goings S, Badiu J, Walker J, Colditz GA, James AS. A stepped-wedge randomized trial protocol of a community intervention for increasing lung screening through engaging primary care providers (I-STEP). Contemp Clin Trials. 2020 Apr;91:105991. doi: 10.1016/j.cct.2020.105991. Epub 2020 Mar 14.

Related Links

Study Officials

  • Aimee S James, Ph.D., MPH

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Graham A Colditz, M.D., DrPH

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
SEQUENTIAL
Model Details: This is a stepped wedge cluster randomized trial in which the intervention condition (toolbox) is sequentially assigned to participating hospitals (screening centers) in 6 clusters at different time-delays and where pre-intervention data serves as the control. By the end of the study, all clusters have been exposed to the intervention and each cluster has provided data for the control and intervention conditions. Independent samples of primary care providers are enrolled at each period within a cluster, thus, it is a repeated cross-sectional study. The order of the entry into the intervention phase is randomized based on levels of readiness
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2019

First Posted

May 21, 2019

Study Start

April 22, 2019

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will share

Practice level and screening center aggregate numbers may be made available to investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary") identified for this purpose

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
Beginning in 3 months and ending 5 years following article publication
Access Criteria
Proposals should be directed to aimeejames@wustl.edu. To gain access, data requestors will need to sign a data access agreement.

Locations